Browsing by Author Duchesne, Gillian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2014Around the globe-radiation oncology in AustraliaTurner, Sandra Lynne; Cronje, Sonja; Duchesne, Gillian; Central Clinical School: MedicineAround the globe-radiation oncology in Australia, International Journal of Radiation Oncology, Biology, Physics, vol.90, 1, 2014,pp 1-6
2009Comparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markersCox, Jennifer; Owen, Rebecca; Cleeve, Laurence; Cramb, Jim; Duchesne, Gillian; Foroudi, Farshad; Kron, Tomas; Laferlita, Marcus; Milner, Alvin D.; Sparks, Laura; Zhu, Li; Medical Imaging and Radiation Sciences; Medical Radiation SciencesComparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markers, International Journal of Radiation: Oncology - Biology - Physics, vol.74, 3,pp 906-912
2010A Comparison of In-Room Computerized Tomography Options for Detection of Fiducial Markers in Prostate Cancer RadiotherapyCox, Jennifer; Owen, Rebecca; Cramb, Jim; Duchesne, Gillian; Foroudi, Farshad; Kron, Tomas; Milner, Alvin D.; Zhu, Li; Medical Imaging and Radiation Sciences; Medical Radiation SciencesA Comparison of In-Room Computerized Tomography Options for Detection of Fiducial Markers in Prostate Cancer Radiotherapy, International Journal of Radiation: Oncology - Biology - Physics, vol.77, 4,pp 1248-1256
2014A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bedCarter, Hannah; Martin, Andrew; Schofield, Deborah; Duchesne, Gillian; Haworth, Annette; Hornby, Colin; Jackson, Michael; Sidhom, M.; Anaesthesia; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed, Radiotherapy and Oncology, vol.112, 2, 2014,pp 187-193
2008The detectability and localization accuracy of implanted fiducial markers determined on in-room computerised tomography (CT) and electronic portal images (EPI)Cox, Jennifer; Duchesne, Gillian; Cramb, Jim; Foroudi, F.; Kron, Tomas; Owen, Rebecca; Sparks, Laura; Medical Imaging and Radiation Sciences; Health SciencesThe detectability and localization accuracy of implanted fiducial markers determined on in-room computerised tomography (CT) and electronic portal images (EPI), Medical Dosimetry, vol.33, 3, 2008,pp 226-233
2017Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialKing, Madeleine; Stockler, Martin; Turner, Sandra Lynne; Woo, Henry; Ames, Alice; Bowe, Steven J.; D'Este, Catherine; Duchesne, Gillian; Frydenberg, Mark; Loblaw, Andrew; Malone, Shawn; Millar, Jeremy; Tai, Keen Hun; Psychology; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; SAHCS: SurgeryHealth-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial, The Lancet Oncology, vol.18, 9, 2017,pp 1192-1201
2014A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trialWoo, Henry; Davis, Ian D; Duchesne, Gillian; et al, .; Fisher, Richard; Fraser-Browne, Carol; Frydenberg, Mark; Haworth, Annette; Jose, Chakiath; Joseph, David; Pearse, Maria; SAHCS: SurgeryA Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial, BJU International, vol.113, Supplement 2, 2014,pp 7-12
2015Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trialTurner, Sandra Lynne; Atkinson, Chris; Denham, James; Duchesne, Gillian; et al, Various; Joseph, David; Kenny, L.; Lamb, David S; Matthews, John; Spry, N; Steigler, Allison; Central Clinical School: MedicineRadiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial, Radiotherapy and Oncology, vol.115, 3, 2015,pp 301-307
2016Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniquesCarter, Hannah (Verry); Martin, Andrew; Bone, Eric; Duchesne, Gillian; Ebert, Martin Andrew; Gagliardi, Frank; Gibbs, Adrian; Haworth, Annette; Hornby, Colin; Jackson, Michael; Sidhom, Mark; Wood, Maree; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreTesting the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques, Journal of Medical Imaging and Radiation Oncology, vol.60, 1, 2016,pp 129-137
2014The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) - Where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trialWoo, Henry; Duchesne, Gillian; SAHCS: SurgeryThe 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) - Where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial, BJU International, vol.114, Suppl1, 2014,pp 9-12
2016Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialKing, Madeleine; Stockler, Martin; Woo, Henry; Bassett, Julie; Bowe, Steven; D'Este, Catherine; Duchesne, Gillian; et al, .; Frydenberg, M; Ledwich, Leo; Loblaw, Andrew; Malone, Shawn; Millar, Jeremy; Milne, Roger; Psychology; NH&MRC Clinical Trials Centre; SAHCS: SurgeryTiming of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial, Lancet Oncology, vol.17, 6, 2016,pp 727-737
2015Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) FrameworkCarter, Hannah; Gebski, Val; Martin, Andrew; Schofield, Deborah; Amin, Rowena; Besuijen, Deidre; Burmeister, Bryan; Corry, June; Duchesne, Gillian; Grand, Mel; Haworth, Annette; Jackson, Michael; Kovacev, Olga; Kron, Thomas; Ng, Michael; Torony, Joan; Anaesthesia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; PharmacyTrans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework, Journal of Medical Imaging and Radiation Oncology, vol.59, 3, 2015,pp 363-370